- Title: Subtitle
- Soluble Programmed Death-Ligand 1 as a prognostic biomarker for overall survival in patients with Diffuse Large B-Cell Lymphoma: a replication study and combined analysis of 508 patients
- Creators
- Delphine Rossille - Université de RennesImane Azzaoui - Université de RennesAndrew L. Feldman - Mayo ClinicMatthew J MaurerGaëlle Labouré - Université de BordeauxMarie Parrens - Université de BordeauxCéline Pangault - Université de RennesThomas M Habermann - Mayo ClinicStephen M. Ansell - Mayo ClinicBrian K. Link - University of IowaKarin Tarte - Université de RennesThomas E. Witzig - Mayo Clinic in FloridaThierry Lamy - Université de RennesSusan L Slager - Mayo Clinic in FloridaMikaël Roussel - Université de RennesNoel Milpied - Université de BordeauxJames R Cerhan - Mayo Clinic in FloridaThierry Fest - Université de Rennes
- Resource Type
- Letter/Communication
- Publication Details
- Leukemia, Vol.31(4), pp.988-991
- DOI
- 10.1038/leu.2016.385
- PMID
- 28035137
- PMCID
- PMC5915627
- NLM abbreviation
- Leukemia
- ISSN
- 0887-6924
- eISSN
- 1476-5551
- Language
- English
- Date published
- 01/27/2017
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Epidemiology; Internal Medicine
- Record Identifier
- 9984359889402771
Letter/Communication
Soluble Programmed Death-Ligand 1 as a prognostic biomarker for overall survival in patients with Diffuse Large B-Cell Lymphoma: a replication study and combined analysis of 508 patients
Leukemia, Vol.31(4), pp.988-991
01/27/2017
DOI: 10.1038/leu.2016.385
PMCID: PMC5915627
PMID: 28035137
Details
Metrics
17 Record Views